NEW YORK (GenomeWeb News) – Metabolomics diagnostics and services company Metabolon has sued Stemina Biomarker Discovery alleging infringement of two patents, a month-and-a-half after Stemina filed a lawsuit asking a federal court to find that it does not infringe on two sets of patents held by Metabolon.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: issues in reproducibility, circulating DNA predicts breast cancer relapse, and more.

Because of an autoimmune disorder, a man has been shedding live polioviruses for 28 years, according to an analysis appearing in PLOS Pathogens.

Being in a long-term collaboration can increase researchers' citation rates by 17 percent, a recent analysis says.

By analyzing tweets, Canadian researchers examine the public's view of gene patenting.